Death and 193 lung cases linked to vaping — but expert blames THC e-liquid off streets

Organisation: Position: Deadline Date: Location:

AddictionUS health officials are reporting what could be the country’s first death linked to vaping, writes Associated Press in The Guardian. There have been 193 cases of lung disease caused by vaping. But Professor Michael Siegel of Boston University says the cases appear to have involved a THC-containing e-liquid bought off the street – and advising people against e-cigarettes would not be prudent.

Death could be first in US linked to vaping, officials say. Health officials are reporting what could be America’s first death linked to vaping, writes Associated Press in The Guardian. There are also reports of nearly 200 people across the United States suffering respiratory illnesses after vaping.

Officials said on 23 August that an adult patient in Illinois, who contracted a serious lung disease after vaping, had died and that they considered it the first death in the US linked to e-cigarettes.

The Illinois Department of Public Health received the report of the death on 22 August, said the chief medical officer, Dr Jennifer Layden.

Officials with the Centers for Disease Control and Prevention said 193 people in 22 states had contracted severe respiratory illnesses after vaping. However, they said a clear common cause of the illnesses had not been identified and that they were being called “potential cases” that were still under investigation.

Ileana Arias, a CDC official, said: “Investigators haven’t identified any specific product or compound that is linked to all of the cases.” She added that the patients might be dealing with different illnesses that had similar symptoms.

All of the illnesses had occurred in teens or adults who had used an e-cigarette or other kind of vaping device. Doctors said the illnesses resembled an inhalation injury, with the lungs apparently reacting to a caustic substance. So far, infectious diseases have been ruled out.

The illnesses had been reported since late June, but the total count rose quickly in the last week. That may be partly because cases that weren’t initially being linked to vaping had begun to be grouped that way.


First death related to vaping recorded in the US. Illinois health officials have announced that a patient who contracted a serious lung disease after vaping has died, which could make it the first death in the US linked to the smoking alternative that has become popular with teens and young adults, says a PBSreport.

The Illinois Public Health Department said that the patient, who was between 17 and 38 years old, had been hospitalised after falling ill following vaping, though it didn’t give other information about the person, including the patient’s name, hometown or date of death.

The report says the US Centres for Disease Control and Prevention had previously issued a news release in which it said 149 people nationwide had contracted a severe respiratory illness after vaping, but that there hadn’t been any deaths reported as of then. CDC officials didn’t immediately reply to requests seeking comment.

The Illinois agency said in its release that the number of people who contracted a respiratory illness after vaping had doubled in the past week, to 22. “The severity of illness people are experiencing is alarming and we must get the word out that using e-cigarettes and vaping can be dangerous,” IDPH director Dr Ngozi Ezike said. “We requested a team from the CDC to help us investigate these cases and they arrived in Illinois on Tuesday.”

All of the illnesses reported by the CDC were in teens or adults who had used an electronic cigarette or some other kind of vaping device. Doctors say the illnesses resemble an inhalation injury, with the lungs apparently reacting to a caustic substance. So far, infectious diseases have been ruled out.

Health officials around the country have been reporting patients getting sick after vaping, two in Connecticut, four in Iowa and six in Ohio. They are asking doctors and hospitals to tell state health officials about any possible vaping-related lung disease cases they encounter.

 

Bias against e-cigarettes putting lives at risk – Dr Michael Siegel. Following 153 reported cases of severe, acute lung disease caused by ‘vaping’, United States authorities have advised people against e-cigarettes. But the cases appear to have involved a THC-containing e-liquid bought off the street, the advice is vague, and it would not be prudent for millions of vapers to return to smoking, blogs Dr Michael Siegel, a professor at Boston University School of Public Health.

Siegel’s article titled “CDC and health groups’ bias against e-cigarettes is putting kids’ lives at risk”, was published on 25 August on his blog“The Rest of the Story: Tobacco and Alcohol News Analysis and Commentary”:

According to the Centers for Disease Control and Prevention (CDC), there have now been 153 reported cases of severe, acute lung disease caused by ‘vaping’ across 19 American states. Tragically, one of these cases resulted in a death. Most of the cases are occurring among youth or young adults.

The acute disease appears to be taking the form of lipoid pneumonia, acute respiratory distress syndrome, and-or chemical pneumonitis.

Physicians, health departments and the CDC have almost uniformly informed the public that these cases are caused by ‘vaping’ and have advised youth and young adults to avoid using e-cigarettes.

The rest of the story

The advice from health agencies, including the CDC, to avoid using e-cigarettes is irresponsible. This is such a broad category of products that it doesn’t really give people any guidance whatsoever in terms of what to avoid.

There are millions of people who are vaping nicotine-containing e-liquids and it would not be prudent for these millions of people to return to smoking in order to avoid the risk of this ‘unknown’ and ‘mysterious’ medical condition. Moreover, with such vague advice, no one is likely to change their behaviour because they are not being warned about any specific, identifiable risk.

The truth is that in every case so far in which a specific e-liquid has been identified, that product has been a THC-containing e-liquid, typically purchased off the street and often in open cartridges such that they could contain a contaminant or other drug.

In at least some of the cases, the use of a THC oil, such as butane hash oil, has been implicated. In January of this year, there was a published case report of a severe, acute respiratory illness attributable to the use of butane hash oil.

Apparently, all 21 cases in California were attributed to vaping of marijuana with all the THC e-liquids being purchased on the street. Since lipoid pneumonia is caused by oil inhalation, it seems pretty clear that those cases diagnosed as lipoid pneumonia are being caused by the use of e-liquids that are oil-based, not alcohol-based.

Most nicotine-containing e-liquids are alcohol-based, meaning that they contain as excipients some combination of propylene glycol and glycerin. These products do not pose a risk of lipoid pneumonia. There are some nicotine-containing e-liquids that are oil-based, and these should absolutely be avoided.

Useful recommendations

Although we do not have a single common link between all the reported cases, there are useful recommendations that the CDC could be giving.

At a minimum, they should be telling the public not to vape THC oils, including butane hash oil. Second, they should be telling people not to use any oil-based vaping e-liquid product.

Third, they should be telling people not to use any e-liquid unless you know what is in it – that is, do not buy products off-the-street and stick to products being sold at retail stores, especially closed cartridges where there is no risk of contamination or the presence of unknown drugs.

These would actually be useful recommendations that could possibly help prevent further cases. Instead, the CDC and other health groups are providing such generalised and vague advice that it is essentially meaningless.

Sadly, the failure of CDC and other health agencies to provide appropriate recommendations is putting kids’ lives at risk. Since there has been no admonition to avoid the use of THC oils, kids are going to continue to use these products. This is why the CDC’s recommendations are irresponsible.

Why?

The question is: why are the CDC and other health groups being so broad in their statements, warning broadly against ‘vaping’ or using ‘e-cigarettes’ but failing to warn against the use of THC oil?

The answer, I believe, is that these organisations have such a pre-conceived conclusion that vaping is hazardous and such a bias against the use of e-cigarettes for smoking cessation that they are hoping to be able to attribute these cases to traditional nicotine vaping.

By no means are we in a position currently to be able to conclude that vaping THC oils or other oil-based e-liquids is solely responsible for the observed cases nor are we sure that street-purchased products are solely to blame.

However, I think we know enough to be able to offer a specific recommendation that people not use these products. That CDC has failed to do this is irresponsible, putting lives at risk, and demonstrating the agency’s bias in its views of the science around smoking and vaping.

Dr Michael Siegel is a professor in the Department of Community Health Sciences, Boston University School of Public Health. He has 32 years of experience in the field of tobacco control. He previously spent two years working at the Office on Smoking and Health at CDC, where he conducted research on second hand smoke and cigarette advertising. He has published nearly 70 papers related to tobacco.

CDC and health groups’ bias against e-cigarettes is putting kids’ lives at risk

Patient’s death could be first in US linked to vaping, officials say

CDC, FDA, states continue to investigate severe pulmonary disease among people who use e-cigarettes

PBS report

 

 

 


Receive Medical Brief's free weekly e-newsletter



Related Posts

Thank you for subscribing to MedicalBrief


MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.


Thank you for taking the time to complete the form.